Histopathological section staining
Observe tissue morphology and lesions, including plaque section staining in atherosclerosis research.
Examine tissue pathology with section staining and immunohistochemistry.
Observe tissue morphology and lesions, including plaque section staining in atherosclerosis research.
Immunohistochemistry to examine the distribution of target markers in tissue.
Explore gene expression and protein measures with qPCR, ELISA and WB.
Quantitative PCR analysis to measure target gene expression.
Enzyme-linked immunosorbent analysis to measure target proteins in samples.
Western blot analysis to examine target protein expression.
Explore molecular changes in tissues and cells through transcriptomic data in model research.
Analyze gene expression at single-cell resolution, including hippocampal tissue in Alzheimer’s disease model research.
Sample requirements, assay scope, deliverables and current availability are confirmed for each research project.
组织切片中的蛋白抗原,本条目用于阿尔茨海默病研究时的目标抗原包括:β-淀粉样蛋白(Aβ40、Aβ42 及泛 Aβ 表位,如 4G8 与 Aβ 末端特异性抗体)、异常磷酸化 tau(AT8 表位)、小胶质细胞标记 IBA1 与 F4/80、星形胶质细胞标记 GFAP,以及神经元标记 NeuN。
肿瘤湿重(mg 或 g)
SCFAs
Protocols apply a method to a defined measurement, with samples, procedures and quality controls. Available services are linked separately.
Version 3
This protocol adopts the protocols.io Picrosirius red staining for histology v1. Formalin-fixed paraffin-embedded sections are dewaxed and rehydrated, optionally pre-treated with phosphotungstic acid and counterstained with Weigert haematoxylin, then stained with 0.1% Sirius Red F3BA in saturated picric acid, differentiated with acetic acid, dehydrated, cleared and mounted. Collagen appears red in bright field and birefringent under polarised light. The record describes staining and microscopic observation, not a complete fibrosis area or stage quantification.
Version 3
This protocol adopts the SYBR Green branch of the protocols.io qPCR v1 record. The input is pre-generated cDNA (10 ng per well); RNA extraction and reverse transcription are not included. PowerUp SYBR Green Master Mix and forward/reverse primers are used on a LightCycler 480 with 50˚C for 2 min, 95˚C for 2 min, and 40 cycles of 95˚C for 15 s plus 60˚C for 1 min. CT values are read and analysed by the ΔΔCT method. No specific genes, primer sequences or disease-model readouts are asserted.
Version 2
This protocol adopts the protocols.io Insulin Tolerance Test in Mouse v1. Mice are fasted for 4–6 hours, weighed, and given insulin intraperitoneally at 1–1.2 U/kg. Blood glucose is measured before and at 15, 30, 60, 90 and 120 minutes after injection. The measurement is a glucose assay (OBI:2100020); insulin administration, dose and time points belong to this concrete protocol and are not presented as an exact OBI insulin-tolerance-test term.
Version 2
This protocol adopts the protocols.io Oral Glucose Tolerance Test in Mouse v1. Mice are fasted for 4–6 hours, weighed, and given oral glucose at 1 g/kg (0.5 g/kg after at least 4 weeks of high-fat diet). Blood glucose is measured before and at 15, 30, 60, 90 and 120 minutes after the load, with tail-vein plasma collected at selected time points for insulin measurement. The record describes the assay procedure, not executed disease-model results.
Version 5
Hematoxylin and eosin (H&E) staining of fixed, paraffin-embedded tissue sections (4 μm). The workflow covers dewaxing, rehydration, hematoxylin nuclear staining, bluing, eosin counterstaining, dehydration and clearing, and coverslipping, yielding blue-purple nuclei and pink cytoplasm and connective tissue fibers for light-microscopic assessment of cellular and tissue morphology.
Version 3
Fixative-stored mouse aortas are cleaned, cut open, pinned and imaged with a mm ruler; regional intimal and lesion areas are traced and measured in Image Pro with blinded second-observer verification.
Version 3
Intraperitoneal glucose tolerance test (IPGTT) in mice: single-house for one week, weigh, fast for 6 hours, measure baseline glucose, inject 2 g/kg body weight of 20% D-glucose intraperitoneally, then collect blood at 15 to 120 minutes after injection. Used to assess glucose clearance in obesity and glucose-metabolism models.
Version 1
FFPE kidney sections undergo xylene dewaxing, graded-alcohol hydration, 0.5% periodic-acid oxidation, Schiff development, Mayer hematoxylin counterstain, bluing, dehydration, clearing and Cytoseal mounting, then brightfield scanning at 20x.
Version 1
An accelerating rotarod assay of motor coordination, balance, and motor learning in freely moving mice: ramp duration set to 00:05:00 with speed capped at 50 (instrument default 80) and a minimum of 5; each mouse runs 4 trials per day for 4 consecutive days, with up to 5 animals per group and up to 4 groups per run separated by roughly 15-20 minutes; a trial ends when the animal falls onto the paddle or completes two consecutive rotations, and the daily average time and average rotations across the 4 trials form the readout; the rod is cleaned with 70% ethanol between trials.
Version 1
Hematoxylin and eosin (H&E) staining of fixed, paraffin-embedded tissue sections (4 μm). The workflow covers dewaxing, rehydration, hematoxylin nuclear staining, bluing, eosin counterstaining, dehydration and clearing, and coverslipping, yielding blue-purple nuclei and pink cytoplasm and connective tissue fibers for light-microscopic assessment of cellular and tissue morphology.